Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled trial of tiloronoxim hydrochloride in silicosis
ChiCTR-IIR-17012739Phase 2Recruiting
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tiloronoxim in silicosis (3 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: Change from baseline in forced vital capacity percent predicted at Week 48. Started Sep 2017; status: recruiting.
02
Drugs
tiloronoxim
03
Conditions
silicosis
Beyond the preview
Go deeper on ChiCTR-IIR-17012739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17012739.